These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10637649)

  • 1. 5-HT modifiers as a potential treatment of asthma.
    Cazzola I; Matera MG
    Trends Pharmacol Sci; 2000 Jan; 21(1):13-6. PubMed ID: 10637649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bronchial asthma with tianeptine.
    Lechin F; van der Dijs B; Lechin AE
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):697-701. PubMed ID: 15632955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological, pathophysiological and therapeutic impact of the enteric serotonergic system.
    Molderings GJ
    Arzneimittelforschung; 2012 Apr; 62(4):157-66. PubMed ID: 22438071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic drugs--a possible role in the treatment of psoriasis?
    Thorslund K; Nordlind K
    Drug News Perspect; 2007 Oct; 20(8):521-5. PubMed ID: 18080039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Ago Y; Nakamura S; Baba A; Matsuda T
    J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study.
    Lechin F; van der Dijs B; Orozco B; Jara H; Rada I; Lechin ME; Lechin AE
    Clin Pharmacol Ther; 1998 Aug; 64(2):223-32. PubMed ID: 9728903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serotonin in the pathophysiology of the irritable bowel syndrome.
    Crowell MD
    Br J Pharmacol; 2004 Apr; 141(8):1285-93. PubMed ID: 15100164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
    Glennon RA
    J Med Chem; 2003 Jul; 46(14):2795-812. PubMed ID: 12825922
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropharmacology of 5-hydroxytryptamine.
    Green AR
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S145-52. PubMed ID: 16402098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin research: Crossing scales and boundaries.
    Di Giovanni G; De Deurwaerdère P
    Neuropharmacology; 2020 Dec; 181():108340. PubMed ID: 33007358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV; Buccafusco JJ; Wilson C
    Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin Club. Abstracts of the 6th IUPHAR Satellite Meeting on Serotonin, June 27-30, 2006, Sapporo, Japan.
    J Pharmacol Sci; 2006; 101 Suppl 1():1-150. PubMed ID: 16858763
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.
    Villalón CM; Centurión D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):45-63. PubMed ID: 17703282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes.
    Filip M; Spampinato U; McCreary AC; Przegaliński E
    Brain Res; 2012 Oct; 1476():132-53. PubMed ID: 22494568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene modifiers: a closer look.
    Ramsey LA; Ross BS
    Adv Nurse Pract; 2002 Jun; 10(6):22-4. PubMed ID: 12400356
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of serotoninergic drugs on tremor induced by physostigmine in rats.
    Sarkar S; Thomas B; Muralikrishnan D; Mohanakumar KP
    Behav Brain Res; 2000 May; 109(2):187-93. PubMed ID: 10762688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
    Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
    Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.